R
Rachel B. Slayton
Researcher at Centers for Disease Control and Prevention
Publications - 80
Citations - 3368
Rachel B. Slayton is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 61 publications receiving 2061 citations. Previous affiliations of Rachel B. Slayton include Government of the United States of America & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.
Michael A. Johansson,Talia M. Quandelacy,Sarah Kada,Pragati V. Prasad,Molly C. Steele,John T. Brooks,Rachel B. Slayton,Matthew Biggerstaff,Jay C. Butler +8 more
TL;DR: In this article, a decision analytical model assessed the relative amount of transmission from presymptomatic, never symptomatic, and symptomatic individuals across a range of scenarios in which the proportion of transmissions from people who never develop symptoms (i.e., remain asymptotic) and the infectious period were varied according to published best estimates.
Journal ArticleDOI
Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
Summer E. Galloway,Prabasaj Paul,Duncan MacCannell,Michael A. Johansson,John T. Brooks,Adam MacNeil,Rachel B. Slayton,Suxiang Tong,Benjamin J. Silk,Gregory L. Armstrong,Matthew Biggerstaff,Vivien G. Dugan +11 more
TL;DR: The B.1.7 variant is estimated to have emerged in September 2020 and has quickly become the dominant circulating SARS-CoV-2 variant in England (1) as discussed by the authors.
Journal Article
Vital Signs: Improving Antibiotic Use Among Hospitalized Patients
Scott K. Fridkin,James Baggs,Ryan Fagan,Shelley S. Magill,Lori A. Pollack,Paul Malpiedi,Rachel B. Slayton,Karim Khader,Michael Rubin,Makoto Jones,Matthew H. Samore,Ghinwa Dumyati,Elizabeth Dodds-Ashley,James Meek,Kimberly Yousey-Hindes,John A. Jernigan,Nadine Shehab,Rosa Herrera,L. Clifford McDonald,Amy Schneider,Arjun Srinivasan +20 more
TL;DR: There is ample opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing and reducing potential harm and risk for antibiotic resistance by implementing formal programs to improve antibiotic prescribing in hospitals.
Journal ArticleDOI
The economic burden of community‐associated methicillin‐resistant Staphylococcus aureus (CA‐MRSA)
Bruce Y. Lee,Ashima Singh,Michael Z. David,Sarah M. Bartsch,Rachel B. Slayton,Susan S. Huang,Shanta M. Zimmer,Margaret A. Potter,Charles M. Macal,Diane S. Lauderdale,Loren G. Miller,Robert S. Daum +11 more
TL;DR: An economic simulation model is developed to quantify the costs associated with CA-MRSA infection from the societal and third-party payer perspectives and suggests early identification and appropriate treatment of CA- MRSA infections before they progress could save considerable costs.
Posted ContentDOI
Ensemble Forecasts of Coronavirus Disease 2019 (COVID-19) in the U.S.
Evan L. Ray,Nutcha Wattanachit,Jarad Niemi,Abdul H Kanji,Katie House,Estee Y Cramer,Johannes Bracher,Andrew Zheng,Teresa K. Yamana,Xinyue Xiong,Spencer Woody,Yuanjia Wang,Lily Wang,Robert Walraven,Vishal Tomar,Katherine Sherratt,Daniel Sheldon,Robert C. Reiner,B. Aditya Prakash,Dave Osthus,Michael Lingzhi Li,Elizabeth C. Lee,Ugur Koyluoglu,Pinar Keskinocak,Youyang Gu,Quanquan Gu,Glover E George,Guido España,Sabrina M Corsetti,Jagpreet Chhatwal,Sean M. Cavany,Hannah Biegel,Michal Ben-Nun,Jo W Walker,Rachel B. Slayton,Velma K. Lopez,Matthew Biggerstaff,Michael A. Johansson,Nicholas G. Reich +38 more
TL;DR: This analysis demonstrates that real-time, publicly available ensemble forecasts issued in April-July 2020 provided robust short-term predictions of reported COVID-19 deaths in the United States, highlighting the importance of combining multiple probabilistic models and assessing forecast skill at different prediction horizons.